Compounds > 9,10-dimethyl-1,2-benzanthracene
Page last updated: 2024-08-17

9,10-dimethyl-1,2-benzanthracene and Immunologic Deficiency Syndromes

9,10-dimethyl-1,2-benzanthracene has been researched along with Immunologic Deficiency Syndromes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gershwin, ME; Ikeda, R1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Immunologic Deficiency Syndromes

ArticleYear
DMBA induced papillomas in congenitally athymic (nude) and hereditarily asplenic (Dh/+) mice: contrasts and comparisons with immunologically intact littermates.
    Developmental and comparative immunology, 1978, Volume: 2, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benz(a)Anthracenes; Female; Immunologic Deficiency Syndromes; Male; Mice; Mice, Inbred Strains; Mice, Nude; Papilloma; Skin Neoplasms; Spleen

1978